Sentence examples for subsequent heterogeneity from inspiring English sources

Methodologically, the fact that the FGDs were performed by different moderators did result in variations of moderation style and subsequent heterogeneity in FGDs.

The subsequent heterogeneity in practice settings and in the delivery of the program will further enhance the generalizibility of our study.

The statistical effect model planned a priori was reported in most reviews; however, reviewers either chose a fixed effect model (64%) or reported neither fixed nor random models without adequate explanation of the rationale and whether their choice would be altered by the subsequent heterogeneity assessment of the included studies[ 17].

We assessed how grazing, fire, and biotic and abiotic features in tallgrass prairie influenced establishment and maintenance of low vegetative structure in burned patches, the positive feedback driving the fire-grazing interaction, and subsequent structural heterogeneity across a pasture.

Accordingly, in order to avoid selection bias and to account for unobserved heterogeneity, in subsequent analyses we match the engaged firms to control firms from the same industry that are similar ex ante in size, market-to-book ratio, ESG rating, and profitability.

A later review reported heterogeneity in subsequent studies published up to 2008 (Adam et al, 2008).

Quantifying the degree of BRAF protein expression seen in a tumour may therefore be used as a first step to assess for intra-tumoural heterogeneity, allowing subsequent intra-tumoural sampling to occur, such as microdissection, followed by detailed molecular testing.

Although the proposed scoring algorithm has high specificity for identifying PMR patients,, it is nevertheless unable to predict the subsequent corticosteroid response, suggesting heterogeneity of disease course and treatment response.

Broglio et al 18 assumed a lack of treatment effect beyond progression and showed through simulation that even a substantial benefit in PFS may be attenuated or lost as SPP increases; this is due to the random variability introduced by patient heterogeneity and subsequent therapy.

The selection of the first and second maximum cliques of species with an overlap of at least 100 nucleotides or amino acids [steps IX and X] and the subsequent tests for compositional heterogeneity [steps XI and XII] led to the exclusion of 669 species and reduced the data set to 2,793 species.

This results in some heterogeneity in the subsequent analyses, such as the results shown in figure 3 in the main text.